Atopic Dermatitis Research Network Report issue

Foundation Phase 1 Phase 2 Phase 4
Founded: Denver CO United States (2004)

Organization Overview

First Clinical Trial
2011
NCT01518478
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Atopic Dermatitis Research Network

Active Ingredients

Drugs in Phase 4 Trials (1)

dupilumab (dupixent) (1 trial)

Drugs in Phase 2 Trials (1)

palmityl alcohol (1 trial)

Drugs in Phase 1 Trials (1)

inactivated influenza vaccine (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 4)

Dermatitis, Atopic (Phase 4)

Eczema (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 3